CytomX
+$0.05 (+3.18%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.
About CTMX
CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs.
CEO
Sean A. McCarthy
Employees
174
Headquarters
South San Francisco, California
Founded
2010
CTMX Key Statistics
Market cap
105.95M
Price-Earnings ratio
—
Dividend yield
—
Average volume
815.97K
High today
$1.63
Low today
$1.52
Open price
$1.61
Volume
587.26K
52 Week high
$7.85
52 Week low
$1.51
CTMX News
Analyst ratings
100%
of 9 ratings
Buy
100%
Hold
0%
Sell
0%
CTMX Earnings
-$0.50
-$0.33
-$0.17
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours